4.3 Article

Differences in Pancreatic Cancer Incidence Rates and Temporal Trends Across Asian Subpopulations in California (1988-2015)

Journal

PANCREAS
Volume 48, Issue 7, Pages 931-933

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/MPA.0000000000001337

Keywords

Asians; disparity; ethnicity; incidence; exocrine pancreatic cancer

Funding

  1. American Cancer Society Research Scholar Grant [RSG-16-250-01-CPHPS]
  2. California Department of Public Health [103885]
  3. Centers for Disease Control and Prevention's National Program of Cancer Registries [5NU58DP003862-04/DP003862]
  4. National Cancer Institute's Surveillance, Epidemiology and End Results Program [HHSN261201000140C, HHSN261201000034C, HHSN261201000035C]
  5. National Cancer Institute, Center for Reducing Cancer Health Disparities of the National Institutes of Health [U54CA233396, U54CA233444, U54CA233465]

Ask authors/readers for more resources

Objective Ethnic disparities in pancreatic cancer (PanCan) incidence exist, but little is known about incidence trends in heterogeneous Asian Americans. We examined PanCan incidence and temporal patterns among detailed ethnic populations, including Asian American subgroups. Methods A total of 71,099 invasive exocrine PanCan cases were identified using the California Cancer Registry between 1988 and 2015. Cases were grouped into mutually exclusive groups of non-Hispanic (NH) white, NH black, Hispanic, NH Asian/Pacific Islander (API), and NH American Indian/Alaska Native (AIAN). Asians were further identified by specific ethnicity. Results The age-adjusted incidence rates (AAIRs, per 100,000) of PanCan varied significantly across racial/ethnic groups, ranging from the highest of 10.4 in NH blacks to 7.6 in NH whites, 7.1 in Hispanics, 6.2 in NH APIs, and to the lowest of 5.2 in NH AIAN. Despite the relatively low rate in the NH APIs, the rates across Asian subgroups varied significantly, with rates similar to NH whites in Japanese (8.1) and Koreans (7.5) to the low rate in South Asians (4.4). Conclusions Significant heterogeneity of PanCan incidence in disaggregated Asian Americans is a novel finding. These results fill a gap regarding PanCan burden in Asian Americans and underscore the importance of disaggregating ethnic populations in cancer research.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Survival of Adolescents and Young Adults with Prevalent Poor-Prognosis Metastatic Cancers: A Population-Based Study of Contemporary Patterns and Their Implications

Jessica K. Sheth Bhutada, Amie E. Hwang, Lihua Liu, Kai-Ya Tsai, Dennis Deapen, David R. Freyer

Summary: Although survival rates have improved for most adolescents and young adults with cancer, those with metastatic disease still have poor outcomes. This study compared the survival rates of AYAs and older adults with poor-prognosis metastatic cancers and found that AYAs generally had better survival rates, except for kidney cancer. Disparities in survival rates were also found among different races/ethnicities and socioeconomic statuses. Overcoming the impact of metastasis in these cancers is crucial for improving outcomes in AYA oncology.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)

Article Surgery

Bariatric surgery in patients with breast and endometrial cancer in California: population-based prevalence and survival

Eunjung Lee, Eric S. Kawaguchi, Juanjuan Zhang, Sue E. Kim, Dennis Deapen, Lihua Liu, Nasim Sheidaee, Amie E. Hwang, Irene Kang, Kulmeet Sandhu, Giske Ursin, Anna H. Wu, Agustin A. Garcia

Summary: The study investigated the prevalence of weight loss surgery in women with breast or endometrial cancer, finding that postdiagnosis weight loss surgery was associated with a decreased hazard for death. Approximately 2000 patients in California underwent weight loss surgery after being diagnosed with breast or endometrial cancer.

SURGERY FOR OBESITY AND RELATED DISEASES (2022)

Article Dermatology

Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1 578 482 adults diagnosed during 2000-2014 in 59 countries (CONCORD-3)

Veronica Di Carlo, Charles A. Stiller, Nora Eisemann, Andrea Bordoni, Melissa Matz, Maria P. Curado, Laetitia Daubisse-Marliac, Mikhail Valkov, Jean-Luc Bulliard, David Morrison, Chris Johnson, Fabio Girardi, Rafael Marcos-Gragera, Mario Sekerija, Siri Laronningen, Eunice Sirri, Michel P. Coleman, Claudia Allemani

Summary: This study aims to assess whether differences in morphology can explain global variation in survival for cutaneous melanoma. Results showed that the proportion of nodular melanoma ranged from 7% to 13% worldwide, with acral lentiginous melanoma being more common in Asia and Central and South America. The study highlights the need for specific health policies to improve awareness, early diagnosis, and access to treatment for nodular and acral lentiginous melanomas.

BRITISH JOURNAL OF DERMATOLOGY (2022)

Editorial Material Gastroenterology & Hepatology

Rising Incidence and Racial Disparities of Early-Onset Pancreatic Cancer in the United States, 1995-2018

Brian Z. Huang, Lihua Liu, Juanjuan Zhang, Stephen J. Pandol, Steven R. Grossman, Veronica Wendy Setiawan

GASTROENTEROLOGY (2022)

Article Oncology

Ovarian cancer today and tomorrow: A global assessment by world region and Human Development Index using GLOBOCAN 2020

Citadel J. Cabasag, Paula J. Fagan, Jacques Ferlay, Jerome Vignat, Mathieu Laversanne, Lihua Liu, Maaike A. Aa, Freddie Bray, Isabelle Soerjomataram

Summary: This study provides an overview of the global burden of ovarian cancer and predicts the future burden, particularly in low Human Development Index (HDI) countries. It shows geographic variations in incidence and mortality rates, with higher burden in low HDI countries. The study highlights the need for global action to reduce the burden and inequality of ovarian cancer in access to quality cancer care and treatment.

INTERNATIONAL JOURNAL OF CANCER (2022)

Article Medicine, General & Internal

Trends in Incidence of Metastatic Prostate Cancer in the US

Mihir M. Desai, Giovanni E. Cacciamani, Karanvir Gill, Juanjuan Zhang, Lihua Liu, Andre Abreu, Inderbir S. Gill

Summary: Analysis of the recent SEER data reveals a significant increase in the incidence rates of mPCa, which coincides with the USPSTF recommendations against PCa screening. These trends are observed across different races and age groups and are associated with changes in screening practices.

JAMA NETWORK OPEN (2022)

Article Oncology

Risk of Presenting with Poor-Prognosis Metastatic Cancer in Adolescents and Young Adults: A Population-Based Study

Jessica K. Sheth Bhutada, Amie E. Hwang, Lihua Liu, Kai-Ya Tsai, Dennis Deapen, David R. Freyer

Summary: Despite overall survival improvements for adolescents and young adults with cancer, certain subgroups such as non-Hispanic Blacks, males, and those with low socioeconomic status face increased risk of metastatic disease. Metastatic melanoma stands out for demonstrating multiple sociodemographic disparities. Future cancer-specific studies should investigate the connection between sociodemographic risk factors and biological drivers of metastases to inform targeted public health efforts.

CANCERS (2022)

Article Public, Environmental & Occupational Health

Characterization of mortality and high-risk characteristics of thyroid cancer in Filipinos using the California Cancer Registry

Robert Hsu, Kai-Ya Tsai, Krithika Chennapan, Katherine Y. Wojcik, Alice W. W. Lee, Jorge J. Nieva, Lihua Liu

Summary: Filipino thyroid cancer patients have a higher incidence of high-risk pathological features and greater mortality risk. Further investigation is needed to understand the connection between these factors.

FRONTIERS IN PUBLIC HEALTH (2023)

Article Oncology

Differential trends in rising endometrial cancer incidence by age, race, and ethnicity

Liu Lihua, Talar S. Habeshian, Zhang Juanjuan, Noah C. Peeri, Du Mengmeng, Immaculata De Vivo, Veronica Wendy Setiawan

Summary: The incidence of endometrial cancer, especially early-onset cases, is increasing, with striking differences in demographic and tumor characteristics as well as racial and ethnic patterns. This study utilized data from the Cancer in North America (CiNA) Analytic File to examine trends in invasive endometrial cancer incidence by age and ethnicity. The faster increase in early-onset cases, particularly among non-White women, suggests a possible association with the rising obesity epidemic in younger generations.

JNCI CANCER SPECTRUM (2023)

Article Public, Environmental & Occupational Health

Early onset of nasopharyngeal cancer in Asian/Pacific Islander Americans

Alice W. Lee, Angela Sou, Maitri Patel, Sofia Guzman, Lihua Liu

Summary: The incidence of nasopharyngeal cancer is significantly higher among Asian/Pacific Islanders (APIs) compared to other racial groups. APIs have the highest incidence of nasopharyngeal cancer across all histologic subtypes and almost all age groups.

ANNALS OF EPIDEMIOLOGY (2023)

Article Oncology

Association of nativity with survival among adults with hepatocellular carcinoma

Kali Zhou, Ziwei Song, Nairi Rostomian, Jennifer L. Dodge, Mariana C. Stern, V. Wendy Setiawan, Norah A. Terrault, Myles G. Cockburn, Lihua Liu

Summary: Immigrants make up a significant proportion of HCC patients in the US, and those who are foreign-born have better survival rates compared to US-born patients. Further research is needed to understand the mechanisms behind this survival disparity.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Article Multidisciplinary Sciences

The effect of the COVID-19 pandemic on life expectancy in 27 countries

Guogui Huang, Fei Guo, Klaus F. Zimmermann, Lihua Liu, Lucy Taksa, Zhiming Cheng, Massimiliano Tani, Marika Franklin

Summary: This study assesses the loss of life expectancy caused by COVID-19 in 27 countries by considering both the actual and expected changes in life expectancy between 2019 and 2020. The results show that 21 out of 27 countries would have experienced an increase in life expectancy if COVID-19 had not occurred. Taking into account the expected mortality changes, the study finds that the average loss of life expectancy in 2020 across the 27 countries was 1.33 years at age 15 and 0.91 years at age 65. These findings highlight the profound impact of COVID-19 on mortality when considering year-on-year intrinsic variations, especially in countries with higher life expectancy increase in recent years.

SCIENTIFIC REPORTS (2023)

Article Oncology

Use of the Decipher genomic classifier among men with prostate cancer in the United States

Nicholas G. Zaorsky, James A. Proudfoot, Angela Y. Jia, Raed Zuhour, Randy Vince Jr, Yang Liu, Xin Zhao, Jim Hu, Nicola C. Schussler, Jennifer L. Stevens, Suzanne Bentler, Rosemary D. Cress, Jennifer A. Doherty, Eric B. Durbin, Susan Gershman, Iona Cheng, Lou Gonsalves, Brenda Y. Hernandez, Lihua Liu, Bozena M. Morawski, Maria Schymura, Stephen M. Schwartz, Kevin C. Ward, Charles Wiggins, Xiao-Cheng Wu, Jonathan E. Shoag, Lee Ponsky, Alan Dal Pra, Edward M. Schaeffer, Ashley E. Ross, Yilun Sun, Elai Davicioni, Valentina Petkov, Daniel E. Spratt

Summary: In this study, the Decipher Prostate Genomic Classifier (GC) was used to analyze a US national database of men with prostate cancer. The use of the GC test was found to be associated with conservative management, higher rates of adverse pathology at the time of surgery, and greater use of postoperative radiotherapy.

JNCI CANCER SPECTRUM (2023)

Meeting Abstract Oncology

Rising incidence and racial disparities of early-onset endometrial cancer in the United States, 1995-2018

Talar S. Habeshian, Lihua Liu, Juan-Juan Zhang, Margaret Du, Immaculata De Vivo, Veronica W. Setiawan

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2023)

Meeting Abstract Oncology

Use of ambulatory surgery centers for breast cancer surgery is associated with better survival: A population-based assessment in California

Lihua Liu, Juanjuan Zhang, Kathy Wojcik, Irene Kang, Mary Falcone, Caryn Lerman

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2023)

No Data Available